1068604-40-9

Upstream product

• 915410-93-4 1,3-dibromo-5-((4-methoxybenzyl)oxy)-benzene 
• 68-12-2 N,N-dimethyl-formamide 
• 105-13-5 4-Methoxybenzyl alcohol 
• 626-39-1 1,3,5-trisbromobenzene 

Downstream Products

• 1089730-72-2 3-formyl-5-((4-methoxybenzyl)oxy)benzonitrile 
• 1421341-68-5 C₃₀H₄₉BrO₄Si₂ 
• 1421341-69-6 C₃₂H₅₃NO₅Si₂ 
• 1421341-70-9 C₃₂H₅₀F₃NO₅Si₂ 
• 1421341-71-0 C₂₄H₄₅NO₄Si₂ 
• 1421341-72-1 C₂₄H₄₃NO₅Si₂ 
• 1421341-73-2 C₂₄H₄₅NO₅Si₂ 
• 1421341-66-3 C₄₉H₆₀BrNO₇SSi 
• 1421341-65-2 C₄₃H₄₆BrNO₇S 
• 1068604-44-3 C₁₅H₁₄BrNO₃ 

Relevant academic research and scientific papers

A model study on installation of (Z)-γ-methylglutaconic acid onto the 3-aminophenol core of divergolide A

Divergolide A and its four congeners, divergolide E-H, possess an amido-substituted hydroquinone core, which is biosynthetically transformed from an aromatic starter unit, 3-amino-5-hydroxybenzoic acid (AHBA). The macrocyclic ring of divergolide A and F i

Toward a total synthesis of divergolide A; Synthesis of the amido hydro- Quinone core and the C10-C15 fragment

A ring-closing metathesis (RCM) approach was envisioned for installing the E double bond at the C9 and C10 positions of divergolide A, isolated from a mangrove endophyte. Accordingly, the C10-C15 diene diol fragment and the amido hydroquinone core with the requisite functionalities and stereochemistry have been synthesized by using the norephedrine-based syn-selective glycolate aldol and the anti-selective aldol reactions, respectively. CuI-catalyzed amidation was employed to access the anilide intermediate, which was further transformed into the amido hydroquinone core. Copyright

PROCESS FOR PREPARING TRIAZOLONES

The present process provides a improved method for the preparation of alkylsulfanyl substituted triazoles 2 which are useful intermediates in a new process for the preparation of triazolones

Non-nucleoside reverse transcriptase inhibitors

Compounds of formula I, wherein R1, R2, R3, R4, R5, X, Y, and Ar are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula I useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.